Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $1.09 Million - $1.98 Million
-17,400 Reduced 20.0%
69,600 $7.92 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $5.13 Million - $7.37 Million
87,000 New
87,000 $5.38 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $2 Million - $2.55 Million
23,200 Added 229.7%
33,300 $3.5 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $995,456 - $1.21 Million
10,100 New
10,100 $1.09 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.